share_log

The Analyst Landscape: 5 Takes On Tango Therapeutics

The Analyst Landscape: 5 Takes On Tango Therapeutics

分析師風雲變幻:對探戈生物療法的5種看法
Benzinga ·  11/11 13:00
Tango Therapeutics (NASDAQ:TNGX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Tango Therapeutics(納斯達克:TNGX)在上個季度接受了5位分析師的分析,展現了從看好到看淡的觀點譜系。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況,突出了過去30天內情緒的變化,並將其與之前的月份進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $11.0, with a high estimate of $13.00 and a low estimate of $8.00. Experiencing a 24.66% decline, the current average is now lower than the previous average price target of $14.60.
分析師對12個月價格目標的評估提供了額外的見解,展示了平均目標爲$11.0,最高估值爲$13.00,最低估值爲$8.00。目前的平均值下降了24.66%,現在低於先前的平均價格目標$14.60。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級:全面解析
An in-depth analysis of recent analyst...
對近期分析師行...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論